---
title: "Inventiva Publishes Presentation on Lanifibranor's Antifibrotic Effects in Preclinical Models"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305136113.md"
description: "Inventiva published a presentation on lanifibranor's antifibrotic effects in preclinical models. The investigational drug demonstrated reduced liver fibrosis through balanced pan-PPAR activation, which improved metabolism, dampened inflammation, and supported hepatic cell function. These findings support further development of lanifibranor as a therapy for metabolic dysfunction-associated steatohepatitis (MASH)."
datetime: "2026-11-11T08:36:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305136113.md)
  - [en](https://longbridge.com/en/news/305136113.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305136113.md)
generator: "portal-rs"
---

# Inventiva Publishes Presentation on Lanifibranor's Antifibrotic Effects in Preclinical Models

-   Inventiva published a medical research presentation showing investigational lanifibranor reduced liver fibrosis across preclinical models. \* Balanced pan-PPAR activation improved liver-cell metabolism, dampened macrophage-driven inflammation and supported function across other hepatic cell populations. \* The findings support further development of lanifibranor as an antifibrotic therapy for metabolic dysfunction-associated steatohepatitis (MASH). Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inventiva SA published the original content used to generate this news brief on November 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [IVA.US](https://longbridge.com/en/quote/IVA.US.md)

## Related News & Research

- [J.P. Morgan Raises Inventiva Voting Rights to 5.21%](https://longbridge.com/en/news/305310429.md)
- [Inventiva to present new lanifibranor Phase 3 NATiV3 MASH trial data in Q4 update, AASLD abstracts show](https://longbridge.com/en/news/301071920.md)
- [Anthropic PBC (ANT) Claims Claude Solved The 167 Year Old Riemann Hypothesis](https://longbridge.com/en/news/306374461.md)
- [Zoomability Announces Availability of Q3 2026 Report](https://longbridge.com/en/news/306354193.md)
- [Salesforce (CRM) Chosen To Lead U.S. Backed Super Intelligence Export Group](https://longbridge.com/en/news/306383121.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**